Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 3
2016 1
2017 3
2018 3
2019 4
2020 10
2021 9
2022 13
2023 16
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD.
Rabe KF, Martinez FJ, Ferguson GT, Wang C, Singh D, Wedzicha JA, Trivedi R, St Rose E, Ballal S, McLaren J, Darken P, Aurivillius M, Reisner C, Dorinsky P; ETHOS Investigators. Rabe KF, et al. N Engl J Med. 2020 Jul 2;383(1):35-48. doi: 10.1056/NEJMoa1916046. Epub 2020 Jun 24. N Engl J Med. 2020. PMID: 32579807 Clinical Trial.
Severe eosinophilic asthma in Chinese C-BIOPRED asthma cohort.
Zhang Q, Fu X, Wang C, Shen H, Zhu L, Shi G, Qiu Z, Wen Z, Gu W, Luo W, Zhao L, Chen Y, Lim S, Xiao C, Kang J, Zhang Y, Huang M, Xu J, Huang K, Li Q, Zhang X, Zhao J, Liu X, Sun S, Tang H, He B, Cai S, Chen P, Wei C, Wang G, Chen P, Xie L, Lin J, Tang Y, Han Z, Chung KF, Zhong N; C-BIOPRED consortium. Zhang Q, et al. Among authors: tang y. Clin Transl Med. 2022 Feb;12(2):e710. doi: 10.1002/ctm2.710. Clin Transl Med. 2022. PMID: 35184418 Free PMC article. No abstract available.
Eligibility of C-BIOPRED severe asthma cohort for type-2 biologic therapies.
Deng Z, Jin M, Ou C, Jiang W, Zhao J, Liu X, Sun S, Tang H, He B, Cai S, Chen P, Wu P, Liu Y, Kang J, Zhang Y, Huang M, Xu J, Huang K, Li Q, Zhang X, Fu X, Wang C, Shen H, Zhu L, Shi G, Qiu Z, Wen Z, Wei X, Gu W, Wei C, Wang G, Chen P, Xie L, Lin J, Tang Y, Han Z, Chung KF, Zhang Q, Zhong N; C-BIOPRED Consortium. Deng Z, et al. Among authors: tang y. Chin Med J (Engl). 2023 Jan 20;136(2):230-232. doi: 10.1097/CM9.0000000000002556. Chin Med J (Engl). 2023. PMID: 36752798 Free PMC article. No abstract available.
Osimertinib versus comparator first-generation epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment in patients with advanced EGFR-mutated non-small cell lung cancer: a Chinese, multicenter, real-world cohort study.
Zhang D, Liu X, Shen F, Zhao D, Shi Y, Zhang H, Liu J, Gao X, Chen M, Zhao J, Zhong W, Gao J, He M, Liu Y, Yang X, Qin J, Tang Y, Mu X, Gu Y, Zhang S, Chen X, Pang L, Meng Q, Guo Y, Zhang Y, Li W, Xing P, Cheng Y, Xin T, Li Q, Li Y, Chen J, Gao F, Jin B, Rossi A, Adachi H, Guerrera F, Husain H, Xu Y, Wang M. Zhang D, et al. Among authors: tang y. Transl Lung Cancer Res. 2023 Nov 30;12(11):2229-2244. doi: 10.21037/tlcr-23-577. Epub 2023 Oct 26. Transl Lung Cancer Res. 2023. PMID: 38090527 Free PMC article.
Cohort profile: the China surgery and anesthesia cohort (CSAC).
Yang L, Chen W, Chen D, He J, Wang J, Qu Y, Yang Y, Tang Y, Zeng H, Deng W, Liu H, Huang L, Li X, Du L, Liu J, Li Q, Song H. Yang L, et al. Among authors: tang y. Eur J Epidemiol. 2024 Feb;39(2):207-218. doi: 10.1007/s10654-023-01083-4. Epub 2024 Jan 10. Eur J Epidemiol. 2024. PMID: 38198037 Free PMC article.
Deep Learning Methods for Lung Cancer Segmentation in Whole-Slide Histopathology Images-The ACDC@LungHP Challenge 2019.
Li Z, Zhang J, Tan T, Teng X, Sun X, Zhao H, Liu L, Xiao Y, Lee B, Li Y, Zhang Q, Sun S, Zheng Y, Yan J, Li N, Hong Y, Ko J, Jung H, Liu Y, Chen YC, Wang CW, Yurovskiy V, Maevskikh P, Khanagha V, Jiang Y, Yu L, Liu Z, Li D, Schuffler PJ, Yu Q, Chen H, Tang Y, Litjens G. Li Z, et al. Among authors: tang y. IEEE J Biomed Health Inform. 2021 Feb;25(2):429-440. doi: 10.1109/JBHI.2020.3039741. Epub 2021 Feb 5. IEEE J Biomed Health Inform. 2021. PMID: 33216724 Review.
Evaluation of safety and efficacy of inhaled ambroxol in hospitalized adult patients with mucopurulent sputum and expectoration difficulty.
Zheng Z, Yang K, Liu N, Fu X, He H, Chen H, Xu P, Wang J, Liu M, Tang Y, Zhao F, Xu S, Yu X, Han J, Yuan B, Jia B, Pang G, Shi Y, Kuang M, Shao H, Xiong H, He J, Pan Y, Chen R. Zheng Z, et al. Among authors: tang y. Front Med (Lausanne). 2023 May 25;10:1182602. doi: 10.3389/fmed.2023.1182602. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37305123 Free PMC article.
61 results